Emerging Technology Platforms for Stem Cells

Uma Lakshmipathy is a Principal Scientist at Life Technologies. She has a PhD in life sciences, with academic and industry experience in molecular biology and stem cells. Dr. Lakshmipathy holds two patents and has authored over thirty publications.Jonathan D. Chesnut is an R & D Director at Life Technologies, where he heads the stem cell engineering group. He holds five patents and has authored over twenty publications.Bhaskar Thyagarajan is a Program Manager at Life Technologies. He has a PhD in pharmacology, with expertise in the areas of molecular biology, DNA recombination, gene and cell therapy, and protein purification. He holds one patent and has authored over twenty publications.

• Foreword Current state of stem cell field: Overview (Mahendra S. Rao). Chapter 1: Derivation methods for human embryonic stem cells: Past, present & future Necati Findikli.Mohan Vemuri.Chapter 2: Isolation of human ESCs from various stages of the human embryo (Yuri Verlinsky, N. Strelchenko, V. Kukharenko, A. Shkumatov, S. Rechitsky, O. Verlinsky, and A. Kuliev).Chapter 3: Derivation of stem cells from epiblasts (Michal Amit).Chapter 4: Derivation of Embryonic Stem Cells from Parthenogenetic Eggs (Jose Cibelli).Chapter 5: Reprogramming Developmental Potential (Costas A. Lyssiotis Cradley D. Charette, and Luke L. Lairson).Chapter 6: Adult stem cells and their role in endogenous tissue repair (N. Sachewsky and Cindi Morshead).Chapter 7: Greater differentiation potential of adult stem cells (Carlos Clavel and Catherine Verfaillie).Chapter 8: Cancer stem cells (Scott Dylla, In-Kyung Park and Austin L. Gurney).Chapter 9: Large scale production of adult stem cells for clinical use (Kristin Goltry, Brian Hampson, Naia Venturi and Ronnda Bartel).Chapter 10: Genetic and epigenetic features of stem cells (Jonathan Auerbach and Richard Josephson).Chapter 11: Directed differentiation of embryonic stem cells (Marjorie Pick).Chapter 12: Identification of signaling pathways involved during differentiation Takumi Miura.Chapter 13 Media and extracellular matrix requirements for large scale ESC growth (Allan J. Robins and Tom Schultz).Chapter 14: Automated method for culturing ES cells (S. Terstegge and Oliver Brustle).Chapter 15: Quantitative 2D Imaging of Human Embryonic Stem Cells (Steven K.W. Oh, Allen K. Chen, Andre B.H. Choo and Ivan Reading).Chapter 16: Nanobiotechonology for stem cell culture and Maintenance (Minseok S. Kim, Wonhye Lee and Je-Kyun Park).Chapter 17: Engineering Microenvironments to Control Stem Cell Functions (Anielle An-Chi Tsou and Song Li).Chapter 18: Improved lentiviral gene delivery tools for stem cells (Sanjay Vasu, Jian-Ping Yang and Wieslaw Kudlicki).Chapter 19: Sleeping Beauty-mediated Transposition in Stem Cells (Andrew Wilbur, Jakub Tolar, Bruce R Blazar, Catherine M Verfaillie, Uma Lakshmipathy, Dan S Kaufman and Scott McIvor).Chapter 20: PhiC31 Integrase for Modification of Stem Cells (W. Edward Jung and Michelle Calos).Chapter 21: Cell Engineering using Integrase and Recombinase systems (Takefumi Sone, Fumiko Nishi, Kazuhide Yahata, Yukari Sasaki, Hiroe Kishine, Taichi Andoh, Ken Inoue, Bhaskar Thyagarajan, Jonathan D. Chesnut and Fumio Imamoto).Chapter 22: hESC derived cardiomyocytes for cell therapy and drug discovery (William Sun and Robert Zweigerdt).Chapter 23: hESC in Drug discovery (Catharina Ellerstrom, Petter Bjorquist, Peter Sartipy, Johan Hyllner and Raimund Strehl).Chapter 24: Characterization and Culturing of Adipose-Derived Precursor Cells (Dietmar Hutmacher, Joanna Olkowska-Truchanowicz, David Leong, Johannes Reichert and Thiam Chye Lim).Chapter 25: Bringing Mesenchymal stem cells to clinic (Robert Deans).